| Product Code: ETC10707010 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The ophthalmic drugs and devices import shipments to Belgium in 2024 continued to show a high concentration with the top exporting countries being Switzerland, USA, Germany, Netherlands, and Metropolitan France. The industry experienced a steady growth with a Compound Annual Growth Rate (CAGR) of 2.85% from 2020 to 2024. Furthermore, the growth rate in 2024 increased by 5.35% compared to the previous year, indicating a positive trend in the market. This data suggests a promising outlook for the ophthalmic sector in Belgium and highlights the importance of these key importing countries in driving growth and innovation.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Ophthalmic Drugs Devices Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, 2022 & 2032F |
3.3 Belgium Ophthalmic Drugs Devices Market - Industry Life Cycle |
3.4 Belgium Ophthalmic Drugs Devices Market - Porter's Five Forces |
3.5 Belgium Ophthalmic Drugs Devices Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Belgium Ophthalmic Drugs Devices Market Revenues & Volume Share, By Delivery Method, 2022 & 2032F |
3.7 Belgium Ophthalmic Drugs Devices Market Revenues & Volume Share, By Device Type, 2022 & 2032F |
3.8 Belgium Ophthalmic Drugs Devices Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.9 Belgium Ophthalmic Drugs Devices Market Revenues & Volume Share, By Formulation, 2022 & 2032F |
4 Belgium Ophthalmic Drugs Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of eye diseases and disorders in Belgium |
4.2.2 Technological advancements in ophthalmic drugs and devices |
4.2.3 Growing awareness about eye health and the importance of early diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of ophthalmic drugs and devices |
4.3.2 High cost associated with advanced ophthalmic treatments |
4.3.3 Limited healthcare infrastructure in certain regions of Belgium |
5 Belgium Ophthalmic Drugs Devices Market Trends |
6 Belgium Ophthalmic Drugs Devices Market, By Types |
6.1 Belgium Ophthalmic Drugs Devices Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Injectable, 2022 - 2032F |
6.1.4 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Oral, 2022 - 2032F |
6.1.5 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Ointments, 2022 - 2032F |
6.1.6 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Eye Drops, 2022 - 2032F |
6.2 Belgium Ophthalmic Drugs Devices Market, By Delivery Method |
6.2.1 Overview and Analysis |
6.2.2 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Topical, 2022 - 2032F |
6.2.3 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Implantable, 2022 - 2032F |
6.2.4 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Nasal Spray, 2022 - 2032F |
6.2.5 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Ophthalmic Patches, 2022 - 2032F |
6.3 Belgium Ophthalmic Drugs Devices Market, By Device Type |
6.3.1 Overview and Analysis |
6.3.2 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Diagnostic Devices, 2022 - 2032F |
6.3.3 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Surgical Instruments, 2022 - 2032F |
6.3.4 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Vision Correction, 2022 - 2032F |
6.3.5 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Diagnostic Imaging, 2022 - 2032F |
6.4 Belgium Ophthalmic Drugs Devices Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Glaucoma, 2022 - 2032F |
6.4.3 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Cataract, 2022 - 2032F |
6.4.4 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Dry Eye, 2022 - 2032F |
6.4.5 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Retinal Disorders, 2022 - 2032F |
6.5 Belgium Ophthalmic Drugs Devices Market, By Formulation |
6.5.1 Overview and Analysis |
6.5.2 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Liquid, 2022 - 2032F |
6.5.3 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Gel, 2022 - 2032F |
6.5.4 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Cream, 2022 - 2032F |
6.5.5 Belgium Ophthalmic Drugs Devices Market Revenues & Volume, By Powder, 2022 - 2032F |
7 Belgium Ophthalmic Drugs Devices Market Import-Export Trade Statistics |
7.1 Belgium Ophthalmic Drugs Devices Market Export to Major Countries |
7.2 Belgium Ophthalmic Drugs Devices Market Imports from Major Countries |
8 Belgium Ophthalmic Drugs Devices Market Key Performance Indicators |
8.1 Number of new product launches in the ophthalmic drugs and devices market |
8.2 Adoption rate of advanced ophthalmic technologies in healthcare facilities |
8.3 Percentage increase in funding for research and development of ophthalmic treatments in Belgium |
9 Belgium Ophthalmic Drugs Devices Market - Opportunity Assessment |
9.1 Belgium Ophthalmic Drugs Devices Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Belgium Ophthalmic Drugs Devices Market Opportunity Assessment, By Delivery Method, 2022 & 2032F |
9.3 Belgium Ophthalmic Drugs Devices Market Opportunity Assessment, By Device Type, 2022 & 2032F |
9.4 Belgium Ophthalmic Drugs Devices Market Opportunity Assessment, By Application, 2022 & 2032F |
9.5 Belgium Ophthalmic Drugs Devices Market Opportunity Assessment, By Formulation, 2022 & 2032F |
10 Belgium Ophthalmic Drugs Devices Market - Competitive Landscape |
10.1 Belgium Ophthalmic Drugs Devices Market Revenue Share, By Companies, 2025 |
10.2 Belgium Ophthalmic Drugs Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here